Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
September 20, 2002
INTERNATIONAL IMMUNIZATION NEWS
"Meningitis Vaccine Shortage May Put Kids at Risk"
Toronto Star (www.thestar.com) (09/20/02) P. A8; Lu, Vanessa
Wyeth-Ayerst's pneumococcal meningitis vaccine Prevnar, which was approved in Canada last year, is now in short supply in the country due to manufacturing problems at a U.S. facility. Health Canada's national advisory committee on immunization recommends that the vaccine be administered to all young children. The four-shot series starts at two months of age and costs C$75 to $100 a dose. Canadian doctors are concerned that delay in the vaccination schedule could lead to a lack of protection against the disease. However, a spokesperson for Wyeth-Ayerst Canada said the situation was temporary and noted that "if a child delays one of their shots, as long as they get their [additional] shots, it doesn't compromise the efficacy of the vaccine."
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.